| Efficacy Of Combined Microneedling Plus Tretinoin In Treatment Of Stria Rubra (NCT07154030) | Sohag University | 2025-09-05 |
| Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT (NCT06412510) | Case Comprehensive Cancer Center | 2025-09-05 |
| A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions: (NCT07201584) | Berlin-Chemie AG Menarini Group | 2025-09-05 |
| 68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma (NCT07353229) | Thomas Jefferson University | 2025-09-05 |
| Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC (NCT06726161) | RayzeBio, Inc. | 2025-09-05 |
| A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy Adults (NCT07172321) | Pfizer | 2025-09-05 |
| A Phase I Study of INT-210 Capsules in Healthy Adult Subjects (INT-210-I101) (NCT07616791) | Innatus Therapeutics (Shanghai) Co., Ltd. | 2025-09-04 |
| First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome Carriers (NCT07163403) | Fundacion Clinic per a la Recerca Biomédica | 2025-09-04 |
| Trial on Single/Multiple Ascending Doses for Safety, PK and PD for CBP-0276 in Healthy Subjects (NCT07708831) | Clarent Biopharma, Inc. | 2025-09-04 |
| A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA) (NCT07128615) | AstraZeneca | 2025-09-04 |
| Clinical Study of Cizutamig in Systemic Lupus Erythematosus (NCT07215663) | Candid Therapeutics | 2025-09-04 |
| A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases (NCT07115745) | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 2025-09-04 |
| A Study of GV20-0251 in Advanced or Refractory Solid Tumors (NCT07106827) | West China Hospital | 2025-09-04 |
| A Study of IBI3032 in Chinese Healthy Participants and Participants With Overweight or Obesity (NCT07160400) | Innovent Biologics Technology Limited (Shanghai R&D Center) | 2025-09-04 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity (NCT07142707) | MBX Biosciences | 2025-09-03 |
| A Trial of Regorafenib Plus Lorigerlimab as Neoadjuvant Therapy for Patients With pMMR/MSS, Resectable, Lung-limited Metastatic Colorectal Cancer (NCT07137390) | M.D. Anderson Cancer Center | 2025-09-03 |
| A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT (NCT07061288) | Bristol-Myers Squibb | 2025-09-03 |
| A Phase I/II Study of CAR.70-Engineered IL15-Transduced Cord Blood-Derived NK Cells With TGF-beta Receptor 2 (TGFBR2) Knock Out in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Myeloid Malignancies (NCT06930651) | M.D. Anderson Cancer Center | 2025-09-03 |
| A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects (NCT07099118) | Sunshine Lake Pharma Co., Ltd. | 2025-09-03 |
| Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors (NCT07145255) | MBrace Therapeutics | 2025-09-03 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBD09 (NCT07094932) | Gates Medical Research Institute | 2025-09-03 |
| Phase 1 Single and Multiple Ascending Dose of LTG-321 in Healthy Participants (NCT07110610) | Latigo Biotherapeutics | 2025-09-03 |
| A Study of GNTI-122 in Adults Recently Diagnosed With T1D (NCT06919354) | GentiBio, Inc | 2025-09-03 |
| Pilot Trial of Preop Partial Radiation in Breast Cancer Patients (NCT07178665) | Rutgers, The State University of New Jersey | 2025-09-02 |
| A Study to Evaluate Adverse Events, How the Drug is Tolerated, and How the Drug Moves Through the Body of Intravenous Infusions of ABBV-8736 in Adult Healthy Volunteers (NCT07141199) | AbbVie | 2025-09-02 |
| A Study to Learn if Taking BIIB141 (Omaveloxolone) Affects How Omeprazole is Processed in the Body and About BIIB141's Safety in Healthy Adults Aged 18 to 55 (NCT07149415) | Biogen | 2025-09-02 |
| A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma (NCT07093814) | Guangzhou Virotech Pharmaceutical Co., Ltd. | 2025-09-02 |
| A Master Protocol Study to Investigate Biomarker-guided Novel Anticancer Agent(s) as Monotherapy or Combination Therapy in Participants With Advanced/Recurrent Ovarian Cancer (NCT07060365) | AstraZeneca | 2025-09-02 |
| A Clinical Trial to Evaluate the Effect of Grapefruit Juice on the PK/PD of Edoxaban (NCT07113054) | Hyewon Chung | 2025-09-02 |
| A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors (NCT07169994) | MediLink Therapeutics (Suzhou) Co., Ltd. | 2025-09-02 |
| Nurse-Led Elderly Sleep Intervention (NCT07251452) | University of Castilla-La Mancha | 2025-09-01 |
| The Efficacy and Safety Study of CAR-T Cells for Functional Cure in HIV-1/AIDS Patients (NCT06880380) | Institute of Hematology & Blood Diseases Hospital, China | 2025-09-01 |
| A Phase I Study of KLA318-2 Nanocrystal Injection (NCT07171034) | Hunan Kelun Pharmaceutical Co., Ltd. | 2025-09-01 |
| Safety, Tolerability and Efficacy of GcMAF in Patients With Chronic Inflammatory Diseases (NCT06877364) | S.LAB (SOLOWAYS) | 2025-09-01 |
| A Phase I/II Study of TRS005 in Combination With Cyclophosphamide, Doxorubicin, and Prednisone（T-CHP） in Previously Untreated Patients With CD20-positive DLBCL (NCT07035379) | Zhejiang Teruisi Pharmaceutical Inc. | 2025-09-01 |
| A Study to Evaluate the Safety and Tolerability of EP0089 (NCT07030478) | Ellipses Pharma | 2025-09-01 |
| Prospective Clinical Study on Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Childhood Autism (NCT07243561) | Dongfang People's Hospital | 2025-09-01 |
| CGM-Guided Acarbose for Painful Diabetic Neuropathy (NCT07436585) | Shifa International Hospital | 2025-09-01 |
| Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets (NCT07172126) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2025-09-01 |
| Assessment of Safety and Efficacy of OPM-101 Combined With Anti-PD-1 in Patients With Advanced Melanoma Showing Resistance to Anti-PD-1 (NCT07040436) | Oncodesign Precision Medicine | 2025-09-01 |
| Clinical Trial of HY004 Cell Injection in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NCT06005649) | Juventas Cell Therapy Ltd. | 2025-09-01 |
| Assessing Gut Microbiome Changes Before and After an Oral Nutritional Supplement Intake Using the SIMBA Capsule in Diabetic Participants (NCT06704022) | Nimble Science Ltd. | 2025-09-01 |
| A Comparative Study Between Dexmedetomidine Versus Methylprednisolone on Induced Inflammatory Response in Patients Undergoing On-pump CABG (NCT07101367) | Ain Shams University | 2025-09-01 |
| A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR) (NCT06232083) | Anhui Provincial Hospital | 2025-09-01 |
| Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid Tumors (NCT07142837) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2025-09-01 |
| A Randomized Controlled Trial of Combined Bu Shen Yi Qi Decoction and Dehydroepiandrosterone (DHEA) for the Treatment of Ovarian Function Decline (NCT07535983) | Jiangxi University of Traditional Chinese Medicine | 2025-09-01 |
| Microneedle Treatment of Chronic Phase Peyronie's Disease: A Pilot Clinical Trial (NCT07128420) | Ottawa Hospital Research Institute | 2025-09-01 |
| A Research Study to Evaluate BLX-0871 in Healthy Adults (NCT07140081) | Biolexis Therapeutics | 2025-09-01 |
| Endostatin Adenovirus With Checkpoint Inhibitor in Advanced Head and Neck or Esophageal Cancer (NCT07154108) | Sichuan University | 2025-09-01 |
| Phase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positive Hematological Malignancies (NCT07110194) | Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | 2025-09-01 |
| CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation (NCT07117305) | Zhengzhou University | 2025-09-01 |
| Effects of Different Administration Routes of Dexmedetomidine on Postoperative Sleep Quality in Patients Undergoing Thyroidectomy (NCT07622355) | The Second People's Hospital of Huai'an | 2025-09-01 |
| Human Umbilical Cord Blood Infusion in Patients with Cerebral Palsy (NCT06377982) | StemCyte Taiwan Co., Ltd. | 2025-09-01 |
| A Phase I/IIa Study of EF-009 in Patients with Pancreatic Cancer (NCT04381130) | Everfront Biotech Co., Ltd. | 2025-09-01 |
| Neutralizing Interferon Type 1 in Hidradenitis Suppurativa (NCT07067099) | Centre Hospitalier Universitaire de Besancon | 2025-09-01 |
| A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects (NCT07319364) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2025-09-01 |
| Application of PD-1 Inhibitors, Tenofovir, Chidamide, and Lenalidomide in Relapsed/Refractory EBV-associated Lymphoproliferative Disorders. (NCT07133763) | The Affiliated Hospital of Xuzhou Medical University | 2025-09-01 |
| A Robot-assisted Tailored Activity Programme for People With Dementia and Their Caregivers (NCT07239869) | The Hong Kong Polytechnic University | 2025-09-01 |
| A Research Study to Evaluate BLX-7006 in Healthy Adults (NCT07140055) | Biolexis Therapeutics | 2025-09-01 |
| CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer (NCT07057349) | Cytosite Biopharma Inc. | 2025-09-01 |
| Detection of Upper Gastrointestinal Tumour Depth and Demarcation Using Systemic Administration of Indocyanine Green During Endoscopic Submucosal Dissection (NCT07108855) | University Medical Center Groningen | 2025-09-01 |
| Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma (NCT07061626) | Plus Therapeutics | 2025-09-01 |
| The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR T-cell Therapy in Children and Young Adults With Relapsed or Refractory B-cell Malignancies (NCT07020260) | Princess Maxima Center for Pediatric Oncology | 2025-09-01 |
| Clinical Trial to Evaluate the Safety and Immunogenicity of the Vivaxin Vaccine for Malaria Caused by Plasmodium Vivax." (NCT07172724) | Federal University of Minas Gerais | 2025-09-01 |
| Controlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of Care (NCT07096934) | FibroBiologics | 2025-09-01 |
| Efficacy and Mechanism of Fu's Subcutaneous Needling Treatment for Migraine Without Aura (NCT07068815) | Guangzhou University of Chinese Medicine | 2025-09-01 |
| Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma (NCT07131345) | National Cancer Center, China | 2025-09-01 |
| Sildosin as a Male Contraceptive Non Hormonal (NCT07195097) | Benha University | 2025-09-01 |
| PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers (NCT07144176) | Daewoong Pharmaceutical Co. LTD. | 2025-09-01 |
| Guttmann NeuroRecovery - Viability, Safety, and Efficacy of Intrathecal Wharton's Jelly Mesenchymal Stem Cells and Transcutaneous Spinal Cord Stimulation in Chronic Spinal Cord Injury Rehabilitation (NCT06981338) | Institut Guttmann | 2025-09-01 |
| Evaluation of Fluoxetine for Refractory Constipation With Somatic Symptom Disorder Features (NCT06506136) | Zhifeng Zhao, PhD | 2025-09-01 |
| UF-KURE-BCMA CAR-T Cells in Patients With Relapsed or Refractory Multiple Myeloma (NCT06698744) | David Wald | 2025-09-01 |
| A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension (NCT07152444) | Qilu Pharmaceutical Co., Ltd. | 2025-09-01 |
| NG2 and DLL3 CAR-T Cells Targeting Melanoma (NCT07193966) | Shenzhen Geno-Immune Medical Institute | 2025-09-01 |
| Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure (NCT07490054) | Melana Yuzefpolskaya, MD | 2025-09-01 |
| Neuromodulation in Patients With Pulmonary Arterial Hypertension (NCT06802380) | University of Oklahoma | 2025-09-01 |
| The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment (NCT07395960) | Fudan University | 2025-09-01 |
| Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-associated Diseases. (NCT07133776) | The Affiliated Hospital of Xuzhou Medical University | 2025-09-01 |
| A Phase 1B Investigator Initiated Study of Safety and Tolerability of Dexamethasone (D) in Combination With Venetoclax-based Low-Intensity Therapy (LIT) in Treatment-Naïve Acute Myeloid Leukemia (AML): DLIT-AML (NCT07014462) | University of Vermont | 2025-09-01 |
| A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast Cancer (NCT07173556) | Qilu Pharmaceutical Co., Ltd. | 2025-09-01 |
| Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment (NCT07171723) | University Hospital, Gentofte, Copenhagen | 2025-09-01 |
| Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy (NCT07141732) | Joint Stock Company European Medical Centre | 2025-09-01 |
| Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19) (NCT05633446) | Gylden Pharma Ltd | 2025-09-01 |
| A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of MN-08 Tablets (NCT05660863) | Guangzhou Magpie Pharmaceuticals Co., Ltd. | 2025-09-01 |
| Clinical Study of the Safety and Pharmacokinetics of the Drug Fluorothiazinone, a Concentrate for Solution Preparation for Infusion. (NCT07184606) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2025-09-01 |
| "Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Drug B10-FC After Single Administration to Adult Patients". (NCT07156864) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2025-09-01 |
| Ibrutinib Followed by BR (Bendamustine and Rituximab) as a Time-Limited Therapy for Waldenström Macroglobulinemia (NCT07169565) | Institute of Hematology & Blood Diseases Hospital, China | 2025-09-01 |
| Evaluation of Lymphatic Response to Physiotherapy in Patients With Swelling Associated With Superficial Venous Disease (NCT07165340) | The University of Texas Health Science Center, Houston | 2025-09-01 |
| Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases (NCT07184450) | Chongqing Precision Biotech Co., Ltd | 2025-09-01 |
| Evaluation of BH4 Responsiveness in Our PKU Patients (NCT07255599) | Sohag University | 2025-09-01 |
| Pharmacokinetics of Oral Letermovir in Adults With End-Stage Kidney Disease With or Without Haemodialysis (NCT07101055) | Jason A Roberts | 2025-09-01 |
| Study of CM559 in Healthy Subjects (NCT07175506) | Keymed Biosciences Co.Ltd | 2025-09-01 |
| Safety and Efficacy of Epicardial Implantation of Collagen Membranes With Allogeneic Adipose Derived Stem Cells (NCT06956807) | Viscofan | 2025-09-01 |
| A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN (NCT04667013) | Guangzhou Magpie Pharmaceuticals Co., Ltd. | 2025-09-01 |
| OH2 Administered by Intratumoral Injection (NCT05954091) | Binhui Biopharmaceutical Co., Ltd. | 2025-09-01 |
| Esketamine Combined With Magnesium Sulfate for Postoperative Fatigue Syndrome in Patients Undergoing Laparoscopic Cholecystectomy (NCT07131033) | The Second People's Hospital of Huai'an | 2025-09-01 |
| Renal Oximetry-Guided Anesthesia With Near-Infrared Spectroscopy for Improved Postoperative Outcomes (NCT07141693) | Chinese PLA General Hospital | 2025-09-01 |
| Narrative Intervention for Chronic Illness- Heart Failure Trial (NICI-HF) (NCT06097481) | University of Colorado, Denver | 2025-09-01 |
| The Dreamy Jet Study (NCT06919198) | University of Wisconsin, Madison | 2025-09-01 |
| KSV01 Injection for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (NCT07260812) | TCRx Therapeutics Co.Ltd | 2025-09-01 |